1 Hayes, JD & Strange, RC (2000) Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61, 154–166.
2 Strange, RC, Jones, PW & Fryer, AA (2000) Glutathione S-transferase: genetics and role in toxicology. Toxicol Lett , 357–363.
3 Brind, AM, Hurlstone, A, Edrisinghe, D, et al. (2004) The role of polymorphism of glutathines S-transferases GSTM1, M3, P1, T1 and A1 in susceptibility to alcoholic liver disease. Alcohol Alcohol 39, 478–483.
4 Katoh, T, Kaneko, S, Takasawa, S, et al. (1999) Human glutathione S-transferase P1 polymorphism and susceptibility to smoking related epithelial cancer; oral, lung, gastric, colorectal and urothelial cancer. Pharmacogenetics 9, 165–169.
5 Chan, EC, Lam, SY, Fu, KH, et al. (2005) Polymorphisms of the GSTM1, GSTP1, MPO, XRCC1, and NQO1 genes in Chinese patients with non-small cell lung cancers: relationship with aberrant promoter methylation of the CDKN2A and RARB genes. Cancer Genet Cytogenet 162, 10–20.
6 Curran, JE, Weinstein, SR & Griffiths, LR (2000) Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer susceptibility. Cancer Lett 153, 113–120.
7 Casson, AG, Zheng, ZY, Geoffrey, AP, et al. (2006) Genetic polymorphisms of microsomal epoxide hydroxylase and glutathione S-transferases M1, T1 and P1, interactions with smoking, and risk for esophageal (Barrett) adenocarcinoma. Cancer Detect Prev 30, 423–431.
8 Binkova, B, Chvatalova, I, Lnenickova, Z, et al. (2007) PAH–DNA adducts in environmentally exposed population in relation to metabolic and DNA repair gene polymorphisms. Mutat Res 620, 49–61.
9 Masetti, S, Botto, N, Manfredi, S, et al. (2003) Interactive effect of the glutathione S-transferase genes and cigarette smoking on occurrence and severity of coronary artery risk. J Mol Med 81, 488–489.
10 Tamer, L, Ercan, B, Camsari, A, et al. (2004) Glutathione S-transferase gene polymorphism as a susceptibility factor in smoking-related coronary artery disease. Basic Res Cardiol 99, 223–229.
11 Girisha, KM, Gilmour, A, Mastana, S, et al. (2004) T1 and M1 polymorphism in glutathione S-transferase gene and coronary artery disease in North Indian population. Indian J Med Sci 58, 520–526.
12 Strain, JJ, Elwood, PC, Davis, A, et al. (2000) Frequency of fruit and vegetable consumption and blood antioxidants in the Caerphilly cohort of older men. Eur J Clin Nutr 54, 828–833.
13 Park, EJ & Pezzuto, JM (2002) Botanicals in cancer chemoprevention. Cancer Metastasis Rev 21, 231–255.
14 Chen, C & Kong, AN (2004) Dietary chemopreventive compounds and ARE/EpRE signaling. Free Radic Biol Med 36, 1505–1516.
15 Omenn, GS, Goodman, GE, Thornquist, MD, et al. (1996) Risk factors for lung cancer and for intervention effects in CARET, the β-carotene and retinol efficacy trial. J Natl Cancer Inst 88, 1550–1559.
16 Zhong, S, Wyllie, AH, Barnes, D, et al. (1993) Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 14, 1821–1824.
17 Zhong, SL, Zhou, S, Chen, X, et al. (2006) Rapid determination of common mutation in glutathione S-transferase gene by PCR-based methods in healthy Chinese. Clin Chim Acta 364, 205–208.
18 Jacques-Silva, MC, Nogueira, CW, Broch, LC, et al. (2001) Diphenyl diselenide and ascorbic acid changes deposition of selenium and ascorbic acid in liver and brain of mice. Pharmacol Toxicol 88, 119–125.
19 Habig, WH & Jakoby, WB (1981) Assays for differentiation of glutathione S-transferases. Methods Enzymol 77, 398–405.
20 Min, JW, Park, H, Park, B, et al. (2006) Paraoxonase gene polymorphism and vitamin levels during pregnancy: relationship with maternal oxidative stress and neonatal birthweights. Reprod Toxicol 22, 418–424.
21 Agachan, B, Yilmaz, H, Ergen, HA, et al. (2005) Paraoxonase (PON1) 55 and 192 polymorphism and its effects to oxidant-antioxidant system in Turkish patient with type 2 diabetes mellitus. Physiol Res 54, 287–293.
22 Zhong, SL, Zhou, SF, Chen, X, et al. (2006) Relationship between genotype and enzyme activity of glutathione S-transferases M1 and P1 in Chinese. Eur J Pharm Sci 28, 77–84.
23 Tang, JJ, Wang, MW, Jia, EZ, et al. (2010) The common variant in the GSTM1 and GSTT1 genes is related to markers of oxidative stress and inflammation in patients with coronary artery disease: a case-only study. Mol Biol Rep 37, 405–410.
24 Mustafa, MD, Pathak, R, Ahmed, T, et al. (2010) Association of glutathione S-transferase M1 and T1 gene polymorphisms and oxidative stress markers in preterm labor. Clin Biochem 43, 1124–1128.
25 Martin, NJ, Collier, AC, Bowen, LD, et al. (2009) Polymorphisms in the NQO1, GSTT and GSTM genes are associated with coronary heart disease and biomarkers of oxidative stress. Mutat Res 674, 93–100.
26 Dušinská, M, Ficek, A, Horská, A, et al. (2001) Glutathione S-transferase polymorphisms influence the level of oxidative DNA damage and antioxidant protection in humans. Mutat Res 482, 47–55.
27 Wilms, LC, Claughton, TA, De Kok, TM, et al. (2007) GSTM1 and GSTT1 polymorphism influences protection against induced oxidative DNA damage by quercetin and ascorbic acid in human lymphocytes in vitro. Food Chem Toxicol 45, 2592–2596.
28 Tijhuis, MJ, Visker, MH, Aarts, JM, et al. (2007) Glutathione S-transferase phenotypes in relation to genetic variation and fruit and vegetable consumption in an endoscopy-based population. Carcinogensis 28, 848–857.
29 Nijhoff, WA, Mulder, TPJ, Verhagen, H, et al. (1995) Effects of consumption of brussels sprouts on plasma and urinary glutathione S-transferase class-alpha and -pi in humans. Carcinogenesis 16, 955–957.
30 Lampe, JW, Chen, C, Li, S, et al. (2000) Modulation of human glutathione S-transferases by botanically defined vegetable diets. Cancer Epidemiol Biomarkers Prev 9, 787–793.